| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.04 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.098 | 0.04 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.56 | 0.04 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.083 | 0.04 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.04 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.086 | 0.04 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.081 | 0.05 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |